Viridian Therapeutics Inc (NASDAQ:VRDN) currently has a daily average trading volume of 904.20K but it saw 1075194 shares traded in last market. With a market cap of 1.10B USD, the company’s current market price of $13.50 came falling about -3.09 while comparing to the previous closing price of $13.93. In past 52 weeks, the stock remained buoying in the range of price level as high as $27.20 and as low as $9.90. In the recent trading on the day, stock has struck highest price mark of $13.39 while lowest mark touched by it was $14.175.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which downgraded the stock as “Equal Weight” in its note to investors issued on December 19, 2024, recommending a price target of between $37 and $27 for it. Needham issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $30 and $38.
Over the week, VRDN’s stock price is moving -2.32% down while it is -0.22% when we observe its performance for the past one month. Year-to-date it is -29.58% down and over the past year, the stock is showing an upside performance of 11.02%.
Currently, Viridian Therapeutics Inc’s total number of outstanding shares is 81.59M with 0.16% of that held by the insiders while 114.29% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -46.77% and return on equity (ROE) at -49.41%. Stock’s beta reads 0.47. Stock has a price to book (P/B) ratio of 2.65 while price to sale or P/S ratio amounts to 3671.63. Its return on asset (ROA) is -45.42% on average.
